Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strains
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Revista Fitos |
Texto Completo: | https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1392 |
Resumo: | Studies for the development of new drugs do not keep pace with increasing bacterial resistance. The use of essential oil can help in this process since it has a great diversity of aromatic compounds with antimicrobial characteristics, so they can be used synergistically to enhance the effect of the drug. This paper is justified by the importance of testing in vitro of essential oils already known as the original substance front the strains bacterial, Staphylococcus aureus ATCC 25923, Streptococcus pyogenes ATCC 19615, Pseudomonas aeruginosas ATCC 27853 and Escherichia coli ATCC 25922, to praise the research of medicinal plants. The research objectives: evaluate the activity antimicrobial of the Essential Oil of Laurus nobilis L. on strains bacterial, to extract the essential oil; to compare the effectiveness of using essential oil to conventional antibiotics; test the inhibitory effect of commercial oil of Laurel, Laurus nobilis L., and the extracted one. Susceptibility testing with oils essential in isolated ways did not present an expected result against the bacterial strains used. The commercial oil showed a small advantage against the extracted oil. However, the synergism test made with the extracted oil with antibiotics has shown considerable effectiveness for bacteria Escherichia coli and Staphylococcus aureus. |
id |
FIOCRUZ-1_6afc02071394ddfa40430111fbbd8c83 |
---|---|
oai_identifier_str |
oai:ojs.revistafitos.far.fiocruz.br:article/1392 |
network_acronym_str |
FIOCRUZ-1 |
network_name_str |
Revista Fitos |
repository_id_str |
|
spelling |
Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strainsAvaliação das atividades de suscetibilidade e sinergismo com o óleo essencial de Laurus nobilis (Lauraceae) e fármacos antimicrobianos contra cepas bacterianasÓleo essencialAntimicrobianoSinergismoPlantas medicinaisLaurus nobilis LEssential oilAntimicrobialSynergismMedicinal plantsLaurus nobilis LStudies for the development of new drugs do not keep pace with increasing bacterial resistance. The use of essential oil can help in this process since it has a great diversity of aromatic compounds with antimicrobial characteristics, so they can be used synergistically to enhance the effect of the drug. This paper is justified by the importance of testing in vitro of essential oils already known as the original substance front the strains bacterial, Staphylococcus aureus ATCC 25923, Streptococcus pyogenes ATCC 19615, Pseudomonas aeruginosas ATCC 27853 and Escherichia coli ATCC 25922, to praise the research of medicinal plants. The research objectives: evaluate the activity antimicrobial of the Essential Oil of Laurus nobilis L. on strains bacterial, to extract the essential oil; to compare the effectiveness of using essential oil to conventional antibiotics; test the inhibitory effect of commercial oil of Laurel, Laurus nobilis L., and the extracted one. Susceptibility testing with oils essential in isolated ways did not present an expected result against the bacterial strains used. The commercial oil showed a small advantage against the extracted oil. However, the synergism test made with the extracted oil with antibiotics has shown considerable effectiveness for bacteria Escherichia coli and Staphylococcus aureus.Os estudos para o desenvolvimento de novos fármacos não acompanham o mesmo ritmo que cresce a resistência bacteriana. O uso do óleo essencial poderá auxiliar nesse processo, possui uma grande diversidade de compostos aromáticos com características antimicrobianas, podendo ser utilizados de forma sinérgica, para potencializar o efeito do fármaco. O presente trabalho justifica-se pela importância de testar in vitro os óleos essenciais, frente às cepas bacterianas Staphylococcus aureus ATCC 25923, Streptococcus pyogenes ATCC 19615, Pseudomonas aeruginosas ATCC 27853 e a Escherichia coli ATCC 25922, com o intuito de enaltecer a pesquisa de plantas medicinais. Os objetivos da pesquisa consistem em: avaliar a atividade antimicrobiana do óleo essencial de Laurus nobilis L. sobre cepas bacterianas; extrair o óleo essencial; comparar a eficácia do óleo essencial em relação a antibióticos convencionais; testar o efeito inibitório do óleo comercial de Louro, Laurus nobilis L., e o extraído. O teste de suscetibilidade com os óleos essenciais de forma isolada, não apresentou resultado esperado, mas o óleo comercial apresentou uma pequena vantagem contra o óleo extraído, porém o teste de sinergismo realizado com o óleo extraído e os antibióticos revelaram uma efetividade considerável para as bactérias Escherichia coli e Staphylococcus aureus.Centro de Inovação em Biodiversidade e Saúde - Farmanguinhos/Fiocruz2022-12-20info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/htmltext/xmlhttps://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/139210.32712/2446-4775.2022.1392Revista Fitos; Vol. 16 No. 4 (2022); 431-442Revista Fitos; Vol. 16 Núm. 4 (2022); 431-442Revista Fitos; v. 16 n. 4 (2022); 431-4422446-47751808-9569reponame:Revista Fitosinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporhttps://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1392/1103https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1392/1104https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1392/1339Copyright (c) 2022 Revista Fitoshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLima, Willian Artner deFernandes, Lidiane Aparecida2022-12-20T17:55:43Zoai:ojs.revistafitos.far.fiocruz.br:article/1392Revistahttps://revistafitos.far.fiocruz.br/index.php/revista-fitos/PUBhttp://revistafitos.far.fiocruz.br/index.php/revista-fitos/oairevistafitos@far.fiocruz.br || eugenio.telles@far.fiocruz.br2446-47752446-4775opendoar:2022-12-20T17:55:43Revista Fitos - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.none.fl_str_mv |
Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strains Avaliação das atividades de suscetibilidade e sinergismo com o óleo essencial de Laurus nobilis (Lauraceae) e fármacos antimicrobianos contra cepas bacterianas |
title |
Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strains |
spellingShingle |
Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strains Lima, Willian Artner de Óleo essencial Antimicrobiano Sinergismo Plantas medicinais Laurus nobilis L Essential oil Antimicrobial Synergism Medicinal plants Laurus nobilis L |
title_short |
Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strains |
title_full |
Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strains |
title_fullStr |
Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strains |
title_full_unstemmed |
Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strains |
title_sort |
Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strains |
author |
Lima, Willian Artner de |
author_facet |
Lima, Willian Artner de Fernandes, Lidiane Aparecida |
author_role |
author |
author2 |
Fernandes, Lidiane Aparecida |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Lima, Willian Artner de Fernandes, Lidiane Aparecida |
dc.subject.por.fl_str_mv |
Óleo essencial Antimicrobiano Sinergismo Plantas medicinais Laurus nobilis L Essential oil Antimicrobial Synergism Medicinal plants Laurus nobilis L |
topic |
Óleo essencial Antimicrobiano Sinergismo Plantas medicinais Laurus nobilis L Essential oil Antimicrobial Synergism Medicinal plants Laurus nobilis L |
description |
Studies for the development of new drugs do not keep pace with increasing bacterial resistance. The use of essential oil can help in this process since it has a great diversity of aromatic compounds with antimicrobial characteristics, so they can be used synergistically to enhance the effect of the drug. This paper is justified by the importance of testing in vitro of essential oils already known as the original substance front the strains bacterial, Staphylococcus aureus ATCC 25923, Streptococcus pyogenes ATCC 19615, Pseudomonas aeruginosas ATCC 27853 and Escherichia coli ATCC 25922, to praise the research of medicinal plants. The research objectives: evaluate the activity antimicrobial of the Essential Oil of Laurus nobilis L. on strains bacterial, to extract the essential oil; to compare the effectiveness of using essential oil to conventional antibiotics; test the inhibitory effect of commercial oil of Laurel, Laurus nobilis L., and the extracted one. Susceptibility testing with oils essential in isolated ways did not present an expected result against the bacterial strains used. The commercial oil showed a small advantage against the extracted oil. However, the synergism test made with the extracted oil with antibiotics has shown considerable effectiveness for bacteria Escherichia coli and Staphylococcus aureus. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-12-20 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1392 10.32712/2446-4775.2022.1392 |
url |
https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1392 |
identifier_str_mv |
10.32712/2446-4775.2022.1392 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1392/1103 https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1392/1104 https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1392/1339 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2022 Revista Fitos https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2022 Revista Fitos https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf text/html text/xml |
dc.publisher.none.fl_str_mv |
Centro de Inovação em Biodiversidade e Saúde - Farmanguinhos/Fiocruz |
publisher.none.fl_str_mv |
Centro de Inovação em Biodiversidade e Saúde - Farmanguinhos/Fiocruz |
dc.source.none.fl_str_mv |
Revista Fitos; Vol. 16 No. 4 (2022); 431-442 Revista Fitos; Vol. 16 Núm. 4 (2022); 431-442 Revista Fitos; v. 16 n. 4 (2022); 431-442 2446-4775 1808-9569 reponame:Revista Fitos instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Revista Fitos |
collection |
Revista Fitos |
repository.name.fl_str_mv |
Revista Fitos - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
revistafitos@far.fiocruz.br || eugenio.telles@far.fiocruz.br |
_version_ |
1798313476062445568 |